In recent weeks, 32-year-old Martin Shkreli, CEO of Turing Pharmaceuticals AG, has become the subject of major public scorn. In September 2015, Shkreli and Turing infamously bought the HIV-fighting drug Daraprim, moved it to a “closed distribution system” and unapologetically raised its price from $13.50 to $750. This led everyone from Congress to Donald Trump to publicly denounce Shkreli. The BBC labeled him the “most hated man in America.” Shkreli promptly doubled-down on the public’s negative perception of him by being the high-profile purchaser (for $2 million) this month of the sole copy of the Wu-Tang Clan’s new album (long but interesting story).
It was with unbridled glee, then, that the media reported that Shkreli was arrested this morning on securities fraud related to a biotechnology firm he founded in 2011 called Retrophin Inc. Here is just a small sample:
